GPX4 and neoplasm: Recent studies found that persistent activation of the mitogen-activated protein kinase (MAPK)/Nrf2 signaling pathway in KRAS mutant tumors specifically induced high expression of FSP1, and this adaptive response enabled tumor cells to maintain REDOX homeostasis through the FSP1–CoQ10 axis after GPX4 inactivation [132].